RxDoctor Payments Data

Muhammad Qadri

Pain Medicine · Atlanta, GANPI 1679869234

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.9% of the total across 207 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Medtronic at 39.4% of the total. Among pain medicine clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,576in general payments, 2019–2025

Across 207 payments — averaging $65.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$5K
  • Biotronik NRO, Inc.$2K
  • Nevro Corp.$2K
  • Abbott$639
  • Stimwave Technologies Incorporated$605
  • SPR Therapeutics, Inc$604
  • plus $3K from 17 others

What the payments were for

  • Travel & lodging$1951%
  • Food & beverage$13,01896%
  • Entertainment$3633%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,576 in reported general payments places this provider in the 90th percentile of 203 pain medicine providers in Georgia.

See all pain medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$99,851
Medicare patients
273
Services billed
1,392

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl25$19,072
Buprenorphine53$11,573
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl117$10,775
Venlafaxine Hcl ErVenlafaxine Hcl465$5,793
Lidocaine19$3,090
Gabapentin206$2,729
Baclofen113$2,667
Duloxetine Hcl143$2,226
Pregabalin93$2,224
Olanzapine OdtOlanzapine13$1,493
Tizanidine Hcl127$1,396
Celecoxib58$1,210
Quetiapine Fumarate83$1,186
Bupropion XlBupropion Hcl62$1,080
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen36$1,065

Paid to pharmacies, not to this prescriber.

Other pain medicine in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →